Premier Asset Management LLC Aldeyra Therapeutics, Inc. Transaction History

Premier Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $1.02 Million - $1.45 Million	-128,579 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $752,452 - $1.07 Million	72,074 Added 127.55%	128,579 $1.46 Million
Q1 2021 May 12, 2021	BUY	$6.53 - $14.42 $368,977 - $814,802	56,505 New	56,505 $671,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $280M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.